Connect with us
BB Biotech actively restructured its portfolio in early 2026, adding eleven stocks and expanding investment guidelines. Its share price outperformed net asset value, narrowing the valuation...
Stocks like BB Biotech should be treated with caution. Nevertheless, there is a quite realistic chance that investors will receive a higher dividend from BB Biotech....
The total shareholder return in 2020 was 19.3% in CHF and 18.1% in EUR, slightly below the performance of the underlying portfolio. In addition to Mersana...